Preschool Neurodevelopmental Outcomes in Children with Congenital Heart Disease

Cheryl L Brosig1, Laurel Bear1, Sydney Allen2

  • 1Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; Herma Heart Center, Children's Hospital of Wisconsin, Milwaukee, WI.

The Journal of Pediatrics
|January 14, 2017
PubMed

Insights

Children with congenital heart disease (CHD) and genetic conditions face the highest neurodevelopmental risks. Mild deficits in children with CHD alone may require formal follow-up testing for detection.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics
  • Genetics

Background:

  • Complex congenital heart disease (CHD) affects neurodevelopmental outcomes.
  • Longitudinal follow-up is recommended by major pediatric organizations.
  • Identifying neurodevelopmental predictors is crucial for early intervention.

Purpose of the Study:

  • To describe preschool neurodevelopmental outcomes in children with complex CHD.
  • To identify predictors of neurodevelopmental outcomes in this population.
  • To inform follow-up care strategies.

Main Methods:

  • Evaluated 102 children (4-5 years old) with high-risk CHD.
  • Utilized standardized neuropsychological assessments and parent-reported functioning.
  • Compared outcomes across single ventricle (1V), two ventricle (2V), and CHD with genetic conditions groups.

Main Results:

  • No significant difference in neurodevelopmental scores between 1V and 2V groups.
  • Both 1V and 2V groups showed mild deficits in fine motor and adaptive behavior skills.
  • Children with CHD and genetic conditions exhibited significantly worse outcomes across most measures compared to other groups and norms.

Conclusions:

  • Children with CHD and co-occurring genetic conditions are at the highest neurodevelopmental risk.
  • Mild deficits in children with CHD without genetic conditions may be missed without formal longitudinal assessment.
  • Enhanced education for parents and providers on developmental follow-up for children with CHD is essential.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
689
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
751